Tevimbra is under clinical development by BeiGene and currently in Phase II for Marginal Zone B-cell Lymphoma.

Eli Lilly is joining in a lawsuit filed by the Outsourcing Facilities against the FDA, aiming to reverse the FDA's October 2024 determination that the shortage has been resolved, which would allow ...

Companies like Pfizer, Amgen, AbbVie, Novartis, and others are advancing Opioid Use Disorder treatments, focusing on improving symptoms and patient ...

Global Type 1 diabetes market is set to grow at a compound annual growth rate (CAGR) of 13.3 per cent from $2.2 billion in ...

Stock futures rose, with Nasdaq-100 leading the gains, rising more than 0.5%. The 10-year Treasury yield ticked lower. It settled at 4.577% Tuesday to close out 2024. Bitcoin traded above $96,000, ...

Tevimbra is under clinical development by BeiGene and currently in Phase II for Follicular Lymphoma. According to GlobalData, Phase II drugs for Follicular Lymphoma have a 43% phase transition success ...

PQE Group, a global consulting firm specializing in Life Sciences, is proud to contribute its expertise as a strategic ...

Southeastern Minnesota had state champions in multiple sports, a Rochester native reached the NBA and one school's tennis ...

Growing awareness about fibromyalgia and advancements in treatment options drive market growth. Generic Medication Accessibility: Enhanced availability of generic medications for fibromyalgia ...

JAMA: Italy's mortality rate is three times higher than China's, and the official reason is revealed With many companies entering the anesthetic market, who will be the dominant player? Eli Lilly to t ...

Differences in how men and women manifest and experience psoriatic arthritis suggest it’s time to think of patient sex as a ...

Pfizer, AstraZeneca, Amgen and several other drug developers aiming to join the weight-loss drug market, which is estimated ...